Carnegie Investment Counsel reduced its position in shares of DuPont de Nemours, Inc. (NYSE:DD – Free Report) by 6.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,538 shares of the basic materials company’s stock after selling 288 shares during the period. Carnegie Investment Counsel’s holdings in DuPont de Nemours were worth $404,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of DD. Palisade Asset Management LLC acquired a new stake in DuPont de Nemours during the 1st quarter worth $25,000. ESL Trust Services LLC acquired a new stake in DuPont de Nemours during the 1st quarter worth $26,000. Strategic Investment Solutions Inc. IL acquired a new stake in DuPont de Nemours during the 2nd quarter worth $27,000. Denver PWM LLC acquired a new stake in DuPont de Nemours during the 2nd quarter worth $28,000. Finally, Fortitude Family Office LLC raised its stake in DuPont de Nemours by 46.6% during the 2nd quarter. Fortitude Family Office LLC now owns 412 shares of the basic materials company’s stock worth $33,000 after acquiring an additional 131 shares in the last quarter. 73.96% of the stock is currently owned by institutional investors and hedge funds.
DuPont de Nemours Stock Up 0.4 %
DD stock opened at $86.85 on Tuesday. The company has a market cap of $36.31 billion, a P/E ratio of 105.91, a P/E/G ratio of 2.26 and a beta of 1.34. DuPont de Nemours, Inc. has a 52 week low of $61.14 and a 52 week high of $90.06. The company’s 50-day moving average price is $82.78 and its 200 day moving average price is $80.11. The company has a current ratio of 2.21, a quick ratio of 1.44 and a debt-to-equity ratio of 0.30.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on the stock. Citigroup dropped their price objective on shares of DuPont de Nemours from $95.00 to $94.00 and set a “buy” rating on the stock in a research note on Friday, July 12th. Barclays lowered shares of DuPont de Nemours from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $88.00 to $84.00 in a research note on Monday, October 7th. Royal Bank of Canada lifted their price objective on shares of DuPont de Nemours from $87.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 5th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of DuPont de Nemours from $92.00 to $98.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. Two analysts have rated the stock with a sell rating, two have given a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.91.
Read Our Latest Stock Report on DuPont de Nemours
DuPont de Nemours Profile
DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- How to Buy Cheap Stocks Step by Step
- Whirlpool’s High Dividend Yield Is Too Good to Pass Up
- 3 Stocks to Consider Buying in October
- Holiday Spending Boom Ahead: 3 BNPL Stocks Poised for Gains
- Buy P&G Now, Before It Sets A New All-Time High
- Boeing: A Perfect Storm of Trouble Is a Loaded Buying Opportunity
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD – Free Report).
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.